Alphamab Oncology Statistics

Total Valuation

HKG:9966 has a market cap or net worth of HKD 8.56 billion. The enterprise value is 7.09 billion.

Market Cap	8.56B
Enterprise Value	7.09B

Important Dates

The last earnings date was Thursday, May 15, 2025.

Earnings Date	May 15, 2025
Ex-Dividend Date	n/a

Share Statistics

HKG:9966 has 961.97 million shares outstanding. The number of shares has increased by 2.53% in one year.

Current Share Class	961.97M
Shares Outstanding	961.97M
Shares Change (YoY)	+2.53%
Shares Change (QoQ)	+4.44%
Owned by Insiders (%)	51.05%
Owned by Institutions (%)	4.86%
Float	470.88M

Valuation Ratios

The trailing PE ratio is 49.20.

PE Ratio	49.20
Forward PE	n/a
PS Ratio	12.57
PB Ratio	4.39
P/TBV Ratio	4.39
P/FCF Ratio	42.22
P/OCF Ratio	37.89
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 37.41, with an EV/FCF ratio of 34.95.

EV / Earnings	40.04
EV / Sales	10.40
EV / EBITDA	37.41
EV / EBIT	65.93
EV / FCF	34.95

Financial Position

The company has a current ratio of 6.74, with a Debt / Equity ratio of 0.10.

Current Ratio	6.74
Quick Ratio	6.41
Debt / Equity	0.10
Debt / EBITDA	1.04
Debt / FCF	0.98
Interest Coverage	10.18

Financial Efficiency

Return on equity (ROE) is 9.49% and return on invested capital (ROIC) is 3.20%.

Return on Equity (ROE)	9.49%
Return on Assets (ROA)	2.88%
Return on Invested Capital (ROIC)	3.20%
Return on Capital Employed (ROCE)	5.08%
Revenue Per Employee	1.62M
Profits Per Employee	421,468
Employee Count	420
Asset Turnover	0.29
Inventory Turnover	0.75

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +82.65% in the last 52 weeks. The beta is 0.41, so HKG:9966's price volatility has been lower than the market average.

Beta (5Y)	0.41
52-Week Price Change	+82.65%
50-Day Moving Average	7.01
200-Day Moving Average	4.42
Relative Strength Index (RSI)	67.36
Average Volume (20 Days)	3,670,363

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:9966 had revenue of HKD 681.16 million and earned 177.02 million in profits. Earnings per share was 0.18.

Revenue	681.16M
Gross Profit	616.97M
Operating Income	107.49M
Pretax Income	177.02M
Net Income	177.02M
EBITDA	175.97M
EBIT	107.49M
Earnings Per Share (EPS)	0.18

Full Income Statement

Balance Sheet

The company has 1.67 billion in cash and 197.89 million in debt, giving a net cash position of 1.47 billion or 1.53 per share.

Cash & Cash Equivalents	1.67B
Total Debt	197.89M
Net Cash	1.47B
Net Cash Per Share	1.53
Equity (Book Value)	1.95B
Book Value Per Share	2.03
Working Capital	1.55B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 225.96 million and capital expenditures -23.17 million, giving a free cash flow of 202.79 million.

Operating Cash Flow	225.96M
Capital Expenditures	-23.17M
Free Cash Flow	202.79M
FCF Per Share	0.21

Full Cash Flow Statement

Margins

Gross margin is 90.58%, with operating and profit margins of 15.78% and 25.99%.

Gross Margin	90.58%
Operating Margin	15.78%
Pretax Margin	25.99%
Profit Margin	25.99%
EBITDA Margin	25.83%
EBIT Margin	15.78%
FCF Margin	29.77%

Dividends & Yields

HKG:9966 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.53%
Shareholder Yield	n/a
Earnings Yield	2.07%
FCF Yield	2.37%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HKG:9966 has an Altman Z-Score of 4.82.

Altman Z-Score	4.82
Piotroski F-Score	n/a